REXAHN PHARMACEUTICALS, INC.·4

Dec 3, 5:10 PM ET

Price Ben Gil 4

4 · REXAHN PHARMACEUTICALS, INC. · Filed Dec 3, 2018

Insider Transaction Report

Form 4
Period: 2018-11-29
Transactions
  • Award

    Stock Option (right to buy)

    2018-11-29+112,878112,878 total
    Exercise: $1.10Exp: 2028-11-29Common Stock (112,878 underlying)
Footnotes (1)
  • [F1]Options will vest and become exercisable based on the following schedule: 37,626 on November 29, 2019, 37,626 on November 29, 2020, and 37,626 on November 29, 2021.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4